Chronic Kidney Disease

July 2nd 2025

The letter cited deficiencies previously identified at a third-party manufacturing vendor unrelated to oxylanthanum carbonate (OLC).

June 24th 2025

Compared with prior intravenous formulations, the autoinjector is a more accessible administration method for children and their caregivers.

June 23rd 2025

Lorundrostat reduces blood pressure and urine albumin-to-creatinine ratio in patients with chronic kidney disease (CKD) and hypertension.

June 17th 2025

The authors note that the combinatorial principal component analysis (cPCA) may be effective in other complex diseases outside of chronic kidney disease (CKD).